
0:00
15:30
Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.
Mais episódios de "Primary Care Pod"
Não percas um episódio de “Primary Care Pod” e subscrevê-lo na aplicação GetPodcast.